For example, studies have shown that BCL6 is essential for the survival of GBM cells (Attarha et al., 2017), the overexpression of BCL6 is associated with poor prognosis for glioma patients, BCL6 gene could inhibits the expression of wild-type p53 and its target genes in GBM cells. Here, TP53 is linked to central nervous system cancer.